太原大便时有鲜红的血山西大便带血是什么问题,太原混合痔手术多长时间,山西痔疮切割手术,太原痔疮越来越大怎么办,太原肛门痒怎么,山西痔疮哪家医院最好,山西痔疮中医叫什么

BEIJING, Nov. 19 (Xinhua) -- China on Saturday again called for appropriately addressing the alleged plot to assassinate the Saudi Arabian Ambassador to the United States.Foreign Ministry Spokesman Liu Weimin made the remarks in a written statement in Beijing.The UN General Assembly on Friday adopted a resolution titled "Terrorist Attacks on Internationally Protected Persons," expressing deep concern over the assassination plot and calling on Iran "to comply with all of its obligations under international law."Liu said China abstained from the vote on the resolution, because the case is highly complicated and sensitive at present and relevant parties still have different views on the issue.He said any conclusion or action must be based on comprehensive, impartial, objective and transparent investigation and substantial evidence."Before facts are checked out, parties should adopt a prudent attitude, refrain from jumping to conclusions, and avoid actions that may complicate and worsen the situation," he said.He said China hopes those countries concerned will continue to appropriately address the issue through dialogue and make joint efforts to maintain peace and stability in the Middle East and the Gulf Region.Liu also reaffirmed that China opposes all forms of terrorism, and always stands for compliance with international law and the basic norms governing international relations in handling state-to-state relations as well as the effective protection of the safety of diplomatic personnel.Chinese Permanent Representative to the United Nations Li Baodong previously addressed the UN General Assembly on Friday in order to explain China's position on the issue after he abstained from voting on the draft resolution.

BEIJING, Jan. 3 (Xinhua) -- A collection of China's nine white papers issued in 2011 has been published in both Chinese and English, according to a statement issued by the publisher on Tuesday.By giving a clear and precise illustration of China's policies, principles and progress in subjects like national defense, law, climate change and international trade, the white papers can help the world know about, and understand, China, the statement said.The white papers are titled, "China's National Defense in 2010," "China's Foreign Aid," "Sixty Years Since the Peaceful Liberation of Tibet," "China's Peaceful Development," "The Socialist System of Laws with Chinese Characteristics," "New Progress in Development-oriented Poverty Reduction Program for Rural China," "China's Policies and Actions for Addressing Climate Change (2011)," "China's Foreign Trade" and "China's Space Activities in 2011."The white papers were all published by the Information Office of the State Council on behalf of the Chinese government.The latest one on space activities was issued last Thursday.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.

NANJING, Jan. 7 (Xinhua) -- Police authorities in China's eastern Jiangsu Province on Sunday intensified their search for the suspect in an armed robbery in the province.Police have increased patrol and initiated a blanket search for the male suspect, who shot and robbed a man in front of a bank in Nanjing, the provincial capital, on Friday, the provincial public security bureau said in a statement.In Nanjing, special armed police and police cars have blocked major roads, with many others searching in public places. Two helicopters are used to facilitate the search.The provincial police authorities also offered a reward of 100,000 yuan (15,850 U.S. dollars) for information leading to the arrest of the man believed to be in his 40s.The suspect shot a man who had just finished withdrawing 200,000 yuan in front of a bank on Nanjing's Dongmen Street at 9:50 a.m. Friday. The robber then took the money and hopped in a car that sped away from the scene of the crime, Pei Jun, deputy chief of the Nanjing public security bureau, said Friday.Pei said the suspect is believed to have used a gun to kill six people and injure another two in six robberies that took place in Changsha, capital of Hunan Province, and Chongqing municipality since 2004.Firearm possession is illegal in China.

SAN FRANCISCO, Nov. 17 (Xinhua) -- Online retail giant Amazon is working on a smartphone scheduled to be released in the fourth quarter of 2012, U.S. media reported Thursday.A note from Citigroup analyst Mark Mahaney obtained by technology news site All Things Digital said that based on the supply chain checks in Asia, Amazon is believed to launch a smartphone in the fourth quarter of 2012.According to the note, Amazon is working with manufacturer Foxconn and the device will run Texas Instruments' OMAP 4 processor. The Kindle Fire, the latest tablet introduced by the e- commerce giant, also uses OMAP processor.The analyst said the smartphone will cost Amazon between 150 and 170 U.S. dollars to build and the company could sell the handset at or near its cost rather than a 30 percent gross margin like many other smartphone manufacturers usually do.The move is expected to further intensify Amazon's rivalry with Apple and Google after the e-commerce giant had made moves on some booming businesses like tablet computer and cloud-computing service.